Neuland Laboratories News and Updates

Keep track of all breaking news on Neuland Laboratories from all sources in a single place.

09 Jul 2026

18899.00

-1.12%

Mukul Agrawal portfolio: Neuland zooms 75% from March low; hits record high

Business Standard

Share price of Neuland Laboratories rallied 6 per cent to hit a record high of 20,072 on the BSE in Thursday's intra-day, after a gap of eight months.

Promoters initiated pledges of 2.29% of holdings in Mar 2026 qtr.

Neuland Laboratories Ltd.

13 May 2026

18899.00

-1.12%

Neuland Laboratories shares rally 7% as profit jumps seven-fold and revenue doubles in Q4

Economic Times

Neuland Laboratories shares saw a significant jump following a strong Q4 performance. The company reported a massive increase in profit and revenue year-on-year. This robust financial result was driven by strong business momentum across key segments. The company is also investing in future growth through strategic initiatives.

Number of FII/FPI investors decreased from 257 to 241 in Mar 2026 qtr

Neuland Laboratories Ltd.

12 May 2026

18899.00

-1.12%

Neuland Laboratories Results Earnings Call for Q4FY26 & Full Year

Conference Call with Neuland Laboratories Management and Analysts on Q4FY26 & Full Year Performance and Outlook. Listen to the full earnings transcript.

audio

Neuland Laboratories Ltd.

12 May 2026

18899.00

-1.12%

to see Rapid results content

Neuland Laboratories Ltd.

09 Feb 2026

18899.00

-1.12%

Neuland Laboratories Results Earnings Call for Q3FY26

Conference Call with Neuland Laboratories Management and Analysts on Q3FY26 Performance and Outlook. Listen to the full earnings transcript.

audio

Neuland Laboratories Ltd.

09 Feb 2026

18899.00

-1.12%

to see Rapid results content

Neuland Laboratories Ltd.

17 Jan 2026

18899.00

-1.12%

Neuland Laboratories: What should investors do?

Business Line

Commercial-scale projects in Neuland Labs' contract manufacturing are expected to reach a critical mass

Neuland Laboratories has gained 32.51% in the last 6 Months

Neuland Laboratories Ltd.

25 Nov 2025

18899.00

-1.12%

Neuland, Lupin, Divi's lead domestic, CDMO surge amid US generics headwinds

Business Standard

Analysts noted that while US generics face margin headwinds, domestic formulations and CDMOs remain resilient. Biosimilars are also poised for growth through new launches and regulatory support.